Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics - Endpoints News
business 2026/07/06 20:27:00

Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics - Endpoints News

Source:Endpoints.news
Author:Kyle LaHucik

Vertex Pharmaceuticals acquires Crinetics Pharmaceuticals for $10B ($85/share), gaining acromegaly drug Palsonify and endocrinology pipeline with ~$5B peak sales potential.